Latest News

Clinical trials are using mRNA technology to develop personalized vaccines intended to prevent cancer from returning.

Davetta Greene got through breast cancer thanks to faith, family and her Hollings Cancer Center team.

The comprehensive care that MUSC provides for people with pancreatitis and pancreatic cancer has been recognized with a center of excellence designation.

After learning she had breast cancer, Patricia Latham agreed to take part in a clinical trial to assess whether some women could avoid radiation.

People with Alzheimer's tend to be less likely to get cancer. Could whatever is happening biologically be harnessed to recharge the immune system?

Life sometimes gets in the way of routine health care. Luckily for Laura Dobbins, she got back on track with screening mammograms right in time.

Treatments for Ewing sarcoma have been essentially the same 30 years. Dr. Casey Langdon wants to change that.

A new clinical trial for women with recurrent ovarian cancer is an outgrowth of a long-term partnership between a researcher, a donor and physicians.

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

MUSC is betting big on its own innovative culture, announcing launch of first venture fund: 1824 Health Ventures Fund I, LP.